EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Compound Analysis and Mechanistic Exploration of Shen‐Yan‐Fang‐Shuai Formula in Diabetic Kidney Disease: An UHPLC‐MS/MS and Bioinformatics Study

Yi Kang iD, Qian Jin iD, Mengqi Zhou, Huijuan Zheng, Danwen Li, Xuezhe Wang, Jingwei Zhou, Jie Lv iD, Yaoxian Wang iD

Journal of Diabetes Research · 2026-01 · 2026 (1)

DOI: 10.1155/jdr/7530512 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Research, online erschienen am 24.04.2026. Verfasst von Yi Kang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China, bucm.edu.cn. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Diabetic Nephropathies. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Traditional Chinese Medicine Scientific Research Project of Hebei Provincial Administration of Traditional Chinese Medicine, Beijing University of Chinese Medicine, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic kidney disease (DKD) is significantly impacting both quality of life and survival rates. The Shen‐Yan‐Fang‐Shuai (SYFS) formula is a traditional Chinese medicine (TCM) compound widely used in the clinical treatment of DKD with proven efficacy, though its potential mechanism of action remains unclear. This study attempts to elucidate the therapeutic efficacy, mechanisms of action, and active compounds of the SYFS formula in the treatment of DKD. Materials and Methods The components of SYFS formula were identified by UHPLC‐MS/MS. Differentially expressed genes (DEGs) and key module genes were selected based on the GEO database to obtain intersection targets. Protein–protein interaction (PPI) network and component‐target network were constructed. Machine learning (ML) was employed to screen for hub genes, which were validated through nomogram, immune infiltration analysis, molecular docking and molecular dynamics (MD) simulation. Subsequently, our findings were validated through a combination of transcriptomic sequencing of renal tissue from animal models and real‐time quantitative PCR (qPCR) analyses performed on both the animal tissues and HK‐2 cells.

Results

154 chemical components and 994 targets were identified in the SYFS formula. Intersection with DEGs and WGCNA module genes identified 39 potential targets. Five hub genes (MMP3, MMP12, PTGES, SST, and DUSP1) were selected through ML and used to construct a nomogram. Multiple immune cell infiltration levels were significantly elevated in DKD, with hub genes showing correlations with specific immune cell types. Molecular docking and MD simulation validated the binding capacity between components of the SYFS formula and key targets. In addition, it has been further verified in animal experiments and cell experiments.

Conclusions

The core components of the SYFS formula, including naringenin chalcone, palmatine, oleanonic acid, β ‐elemonic acid, and Naringenin, likely exert their effects through the MMP3, MMP12, PTGES, SST, and DUSP1 targets. This research offers empirical support for the application of the SYFS formula in DKD, establishing a crucial groundwork for subsequent clinical investigations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalDiabetic NephropathiesAnimalsMolecular Docking SimulationTandem Mass SpectrometryComputational BiologyProtein Interaction MapsHumansChromatography, High Pressure LiquidMolecular Dynamics SimulationRatsDiabetes Mellitus, ExperimentalMaleMachine LearningGene Regulatory Networks

Stichwörter der Autor:innen

UHPLC-MS/MSdiabetic kidney diseasemachine learningmolecular dynamics simulationnetwork pharmacologyshen-yan-fang-shuai formula

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China, bucm.edu.cn.
  • Graduate School of Beijing University of Chinese Medicine, Beijing, China, bucm.edu.cn.
  • Department of Traditional Chinese Medicine, Beijing Puren Hospital, Beijing, China.

ORCID-Profile: Yi Kang, Qian Jin, Jie Lv, Yaoxian Wang

Förderung

  • Traditional Chinese Medicine Scientific Research Project of Hebei Provincial Administration of Traditional Chinese Medicine
  • Beijing University of Chinese Medicine
  • National Natural Science Foundation of China

Zitieren

APA

Kang, Y., Jin, Q., Zhou, M., Zheng, H., Li, D., Wang, X., Zhou, J., Lv, J., & Wang, Y. (2026). Compound Analysis and Mechanistic Exploration of Shen‐Yan‐Fang‐Shuai Formula in Diabetic Kidney Disease: An UHPLC‐MS/MS and Bioinformatics Study. Journal of Diabetes Research, 2026(1). https://doi.org/10.1155/jdr/7530512

Vancouver

Kang Y, Jin Q, Zhou M, Zheng H, Li D, Wang X, et al. Compound Analysis and Mechanistic Exploration of Shen‐Yan‐Fang‐Shuai Formula in Diabetic Kidney Disease: An UHPLC‐MS/MS and Bioinformatics Study. Journal of Diabetes Research. 2026;2026(1). doi:10.1155/jdr/7530512

BibTeX
@article{Kang2026,
  author = {Kang, Yi and Jin, Qian and Zhou, Mengqi and Zheng, Huijuan and Li, Danwen and Wang, Xuezhe and Zhou, Jingwei and Lv, Jie and Wang, Yaoxian},
  title = {Compound Analysis and Mechanistic Exploration of Shen‐Yan‐Fang‐Shuai Formula in Diabetic Kidney Disease: An UHPLC‐MS/MS and Bioinformatics Study},
  journal = {Journal of Diabetes Research},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jdr/7530512}
}
Kostenlos starten →